IGF1 and cardiovascular disorder: Both IGF-1 administration and gain-of-function and loss-of-function approaches in mice have provided mechanistic insights, but consideration of IGF-1 for treatment of cardiovascular disease in humans mandates demonstration of IGF-1’s efficacy and safety in a large animal model that is physiologically closer to humans.